AstraZeneca Says COVID-19 Drug Neutralizes Omicron Variants
Research led by Yoshihiro Kawaoka, a virologist at the University of Wisconsin School of Veterinary Medicine and the University of Tokyo, indicated that other antivirals such as Paxlovid, remdesivir and molnupiravir were effective against the BA.2 variant. The post AstraZeneca Says COVID-19 Drug Neutralizes Omicron Variants appeared first on School of Veterinary Medicine.
SHARE